tadalafil has been researched along with Arteriosclerosis, Coronary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| El-Hajjar, M; Kumar, S; Zheng, WQ | 1 |
| Shaeer, O | 1 |
| Bedding, A; Braat, S; Effron, M; Emmick, J; Kloner, R; MacDonald, T; Mitchell, M; Patterson, D; Warner, M | 1 |
| Carson, CC | 1 |
| Chan, M; Costigan, TM; Hutter, AM; Jackson, G; Kloner, RA; Mittleman, MA; Vail, GM; Warner, MR | 1 |
| Bedding, A; Bergmann, SR; Bokhari, S; Costigan, TM; Emmick, JT; Hickey, K; Shahzad, A; Warner, MR; Weinsaft, JW | 1 |
2 review(s) available for tadalafil and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Blood Pressure; Carbolines; Clinical Trials as Topic; Coronary Artery Disease; Cyclic Nucleotide Phosphodiesterases, Type 5; Electrophysiology; Erectile Dysfunction; Heart Rate; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2005 |
Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
Topics: Aged; Carbolines; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors; Retrospective Studies; Tadalafil | 2006 |
2 trial(s) available for tadalafil and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.
Topics: Aged; Analysis of Variance; Blood Pressure; Carbolines; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Phosphodiesterase Inhibitors; Tadalafil; Vasodilator Agents | 2005 |
Effects of tadalafil on myocardial blood flow in patients with coronary artery disease.
Topics: Adenosine; Aged; Carbolines; Coronary Artery Disease; Coronary Circulation; Cross-Over Studies; Dobutamine; Double-Blind Method; Humans; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Radionuclide Imaging; Tadalafil | 2006 |
2 other study(ies) available for tadalafil and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Fibromuscular dysplasia and coronary artery fistula: links to pulmonary hypertension.
Topics: Aged; Antihypertensive Agents; Coronary Artery Disease; Female; Fibromuscular Dysplasia; Humans; Hypertension, Pulmonary; Phenylpropionates; Pyridazines; Sildenafil Citrate; Tadalafil; Vascular Fistula; Vasodilator Agents | 2020 |
The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers.
Topics: Adult; Aged; Carbolines; Comorbidity; Coronary Artery Disease; Cross-Sectional Studies; Drug Administration Schedule; Drug Utilization; Erectile Dysfunction; Health Surveys; Humans; Illicit Drugs; Imidazoles; Internet; Male; Middle Aged; Nonprescription Drugs; Phosphodiesterase Inhibitors; Piperazines; Prescription Drugs; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; Vardenafil Dihydrochloride | 2013 |